In the context of cancer, IL-1 signalling promotes tumour progression by upregulating matrix metalloproteinases, stimulating pro-angiogenic mediators such as VEGF and prostaglandin E2, and enhancing adhesion molecule expression on endothelial cells, which facilitates tumour cell extravasation and metastasis. Here, IL1A is linked to cancer.